drugset
drugset / Trial / NCT03746067

Safety, Tolerability and Pharmacokinetics of Single Doses of TS-134 in Healthy Volunteers

NCT03746067 ↗

Phase 1 Completed 33 enrolled Taisho Pharmaceutical R&D Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a Phase 1a study involving single oral dose of TS-134 in healthy male and female subjects. The safety, tolerability and pharmacokinetics of single dose of TS-134 will be evaluated.

Timeline

Start
2015-08-21
Primary completion
2016-01-13
Completion
2016-01-13

Drugs

EvaluationDrugModalityDoseRoute
Subject TS-134 Unknown 5 mg Oral
Subject TS-134 Unknown 10 mg Oral
Subject TS-134 Unknown 20 mg Oral

Indications

No indication recorded.